HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/3/E557    most recent 00073.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Yu, H. Articles by Goodyear, L. J. Search for Related Content PubMed PubMed Citation Articles by Yu, H. Articles by Goodyear, L. J.

Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase 3-subunit differentially regulates glycogen accumulation

Research Division, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Submitted 10 February 2006 ; accepted in final form 17 April 2006

AMP-activated protein kinase (AMPK) is a heterotrimeric complex that works as an energy sensor to integrate nutritional and hormonal signals. The naturally occurring R225Q mutation in the 3-subunit in pigs is associated with abnormally high glycogen content in skeletal muscle. Becauses skeletal muscle accounts for most of the body's glucose uptake, and 3 is specifically expressed in skeletal muscle, it is important to understand the underlying mechanism of this mutation in regulating glucose and glycogen metabolism. Using skeletal muscle-specific transgenic mice overexpressing wild type 3 (WT3) and R225Q mutant 3 (MUT3), we show that both WT3 and MUT3 mice have 1.5- to 2-fold increases in muscle glycogen content. In WT3 mice, increased glycogen content was associated with elevated total glycogen synthase activity and reduced glycogen phosphorylase activity, whereas alterations in activities of these enzymes could not explain elevated glycogen in MUT3 mice. Basal, 5-aminoimidazole- AICAR- and phenformin-stimulated AMPK2 isoform-specific activities were decreased only in MUT3 mice. Basal rates of 2-DG glucose uptake were decreased in both WT3 and MUT3 mice. However, AICAR- and phenformin-stimulated 2-DG glucose uptake were blunted only in MUT3 mice. In conclusion, expression of either wild type or mutant 3-subunit of AMPK results in increased glycogen concentrations in muscle, but the mechanisms underlying this alteration appear to be different. Furthermore, mutation of the 3-subunit is associated with decreases in AMPK2 isoform-specific activity and impairment in AICAR- and phenformin-stimulated skeletal muscle glucose uptake.

This article has been cited by other articles:

				S. Park, T. L. Scheffler, A. M. Gunawan, H. Shi, C. Zeng, K. M. Hannon, A. L. Grant, and D. E. Gerrard Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle Am J Physiol Cell Physiol, January 1, 2009; 296(1): C106 - C115. [Abstract] [Full Text] [PDF]

				M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF]

				L. Barre, C. Richardson, M. F. Hirshman, J. Brozinick, S. Fiering, B. E. Kemp, L. J. Goodyear, and L. A. Witters Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E802 - E811. [Abstract] [Full Text] [PDF]